Document is current
Any future updates will be listed below
-
Authors
Zuo, Xiaoxiao
Zhao, Xiaohan
Zhang, Xiaofei
Li, Qingyuan
Jiang, Xingyu
Huang, Shumei
Chen, Xuwei
Chen, Xiangfu
Jia, Weihua
Zou, Hequn
Shi, Dongni
Qian, Xueke
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82303157)
China Postdoctoral Science Foundation (2023M734041)
National Postdoctoral Program for Innovative Talents (BX20230441)
Medical Science and Technology Research Program of Henan Province (LHGJ20190025)
- License Information
-
More Information
Article History
Received: 22 July 2024
Accepted: 22 October 2024
First Online: 6 November 2024
Declarations
:
: Ethics approval (No. B2024-053) and prior patient consents were obtained from the Institutional Research Ethics Committee of Sun Yat-sen University Cancer Center to use the clinical specimens for research purposes. Animal experimental procedures were approved by the Institutional Animal Care and Use Committee of Sun Yat-sen University (No. L102042024000K). According to the guidelines (GB/T35892-2018), the ethics committee specified that the maximal tumor burden is no more than 10% of the body weight of animals and the average diameter is less than 20 mm. During the experiment, the tumor sizes of the mice complied with the regulations. The study complied with the principles set out in the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
: Correspondence to Hequn Zou, Dongni Shi or Xueke Qian.
